New drug shows promise for motor neurone disease treatment

A pioneering study published in the International Journal of Molecular Sciences by researchers at Durham University has revealed promising results for a new treatment targeting motor neurone disease (MND).

Flagship’s Noubar Afeyan on uncertainty, AI and biotech’s future

Flagship Pioneering is known for creating startups that aim to answer broad scientific questions in medicine, sustainability and agriculture, a strategy it describes as leaps

July 11, 2024

Bright Minds Announces Proposed Share Consolidation | Psychedelic Invest

Bright Minds Biosciences Inc. (CSE: DRUG / NASDAQ: DRUG), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy,

June 22, 2023

Half of people worldwide at risk of developing mental health condition by age 75, per new study

By the age of 75, half of people worldwide can expect to experience a mental health disorder, according to the finding of a large study

August 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.